AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05471440 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Post-poned boost mRNA
Description: Participants will be boosted with a covid-19 vaccin after priming with mRNA
Study NCT05471440 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Post-poned boost adeno
Description: Participants will be boosted with a covid-19 vaccin after priming with adeno
Study NCT05580198 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transcranial sonography.
Description: Transcranial sonography examination to determine the brainstem raphe echogenicity.
Study NCT04988399 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki
Description: Reiki is a wellness practice of energy healing that began in Japan and is now practiced throughout the world. The principle of Reiki is that everything in the universe consists of energy including the human body, and deviations of this energy can lead to disease (Doğan 2018). Reiki does not have a religious doctrine and is accepted by people of all backgrounds and belief systems (McManus, 2017, p. 1056). Reiki is considered by practitioners to be a great tool for stress reduction and relaxation (International Association of Reiki Practitioners). Many people use Reiki for wellness. Reiki is not a cure for a disease or illness, but it may assist the body in creating an environment to facilitate healing. According to the Center for Reiki Research, Reiki is an effective approach for reducing pain, depression, and anxiety. Tinnitus is a pain percept, and it is likely Reiki may reduce pain and anxiety in patients with tinnitus.
Study NCT04886388 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BT-001
Description: BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.
Study NCT04886388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physician-guided Standard of Care for type 2 diabetes
Description: Current ADA Standard of Care Guidelines for type 2 diabetes
Study NCT04886388 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physician-guided Standard of Care for type 2 diabetes
Description: Current ADA Standard of Care Guidelines for type 2 diabetes
Study NCT05555862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artesunate
Description: artesunate formulated as intra-anal suppositories
Study NCT06189209 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenalisib
Description: Tenalisib will be administered 800mg BID, orally
Study NCT05046925 — intervention group
Intervention type: PROCEDURE
Intervention: postoperatively transferral to PACU
Description: patients undergoing major thoracic and abdominal surgery will be transferred to PACU for postoperative care.
Study NCT05046925 — intervention group
Intervention type: PROCEDURE
Intervention: postoperatively transferral to ICU
Description: patients undergoing major thoracic and abdominal surgery will be transferred to ICU for postoperative care.
Study NCT06124105 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: arterial blood gases
Description: measurement of partial oxygen pressure in urine by arterial blood gas device
Study NCT06279494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Orally (concentration 5-10ng/ml) from -1 to +100d post haplo-HSCT
Study NCT06279494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Description: 5mg/kg subcutaneous, -1/+5/+14/+28/+42/+56d post haplo-HSCT
Study NCT05555862 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo intra-anal suppository
Study NCT06469307 — intervention group
Intervention type: OTHER
Intervention: DIVERSE Review Process
Description: A participant and community-based review system for clinical research protocols that elicits and collects feedback on investigator-initiated protocol reviews.
Study NCT04908124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lubricant A
Description: Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.
Study NCT04908124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lubricant B
Description: Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.
Study NCT04908124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lubricant C
Description: Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.
Study NCT04908124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lubricant D
Description: Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.
Study NCT04908124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lubricant E
Description: Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.
Study NCT04641195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol)
Description: 180,000 international units (IU) of vitamin D3 at enrollment, followed by 2000 IU once per day from enrollment to 8 weeks
Study NCT04641195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zinc (zinc gluconate)
Description: 40mg of zinc gluconate taken once per day from enrollment to 8 weeks
Study NCT04641195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Zinc (zinc gluconate) & Vitamin D (cholecalciferol)
Description: 180,000 IU of vitamin D3 at enrollment, followed by 2000 IU of vitamin D3 and 40mg of zinc gluconate once per day from enrollment to 8 weeks
Study NCT04641195 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo vitamin D bolus at enrollment followed by placebo daily vitamin D maintenance doses and placebo daily zinc supplements.
Study NCT06279494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MMF
Description: 0.5g bid orally, from -3d to +60d post haplo-HSCT
Study NCT06279494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATG
Description: 2.5 mg/kg, from -5d to -2d
Study NCT05727150 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reconstruction of Soft tissue defects of head and neck by Supraclavicular artery flap
Description: Supraclavicular artery flap will be used in the reconstruction of traumatic and non-traumatic defects of head and neck.Flap harvesting and reconstruction will be performed under general anesthesia. The defect dimensions are measured and the superficial landmarks for the supraclavicular artery are drawn .The flap will be used as island flap, transposed or interpolated flap depending on the arc of rotation needed to achieve flap inset without tension and flap elevation proceeds from lateral to medial.The flap is rotated and inset into the defect
Study NCT06526325 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enhanced golgi tendon organ stimulation
Description: Enhanced Golgi Tendon Organ Stimulation is a method that can be used by physiotherapists and doctors. The Golgi tendon organ is the proprioceptors located in the tendon adjacent to the myotendinous junction. It is applied using two separate heads, the stimulator and the algometer. The sternocleidomastoideus, platysma, colli longus, capitis longus, scalene, rhomboid major and minor, levator scapulae and trapezius muscles and their tendons will be vibrated with a stimulator for 30 seconds, then 0.5 kilograms of pressure will be applied with an algometer from the origin to the insertion of the muscle in the region at 0.5 centimetre intervals at an angle of 90 degrees.
Study NCT06392893 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Meat product without additives and allergens
Description: Baseline time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.~Consumption of meat products without additives and allergens (6 days a week; 5 weeks).~Final time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.
Study NCT06392893 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Commercial meat product
Description: Baseline time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.~Consumption of commercial meat products (6 days a week; 5 weeks).~Final time: Measurement of anthropometric parameters and inflammatory and oxidative markers in blood, faeces and urine.
Study NCT05033483 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ferrous Fumarate
Description: Gelatin capsule containing 200 mg ferrous fumarate and microcrystalline cellulose
Study NCT05033483 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Gelatin capsule containing microcrystalline cellulose
Study NCT06239545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual Practice + JoyPop
Description: Participants will be asked to use the app at least twice daily but will otherwise not be provided with requirements related to feature or total usage.
Study NCT06307171 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: In-house Western blot, specific for Leishmania
Description: Sample will be collected at the collaborating centres and at the DITM, if not already stored at -80°C. The samples will be delivered to the DITM. For the CONTROL groups, two serological tests for Leishmaniasis, based on different antigenic fraction, will be performed on serum samples.~Different strains of Leishmania infantum and Leishmania donovani will be cultivated axenically at the DITM.~Whole soluble fraction of promastigote (WSF), the whole membrane protein fraction (WMF) and the whole soluble fraction secreted by promastigotes (WSFe) of Leishmania spp. will be obtained and the ARPs from WSF, WMF and WSFe, of each Leishmania will be checked trough Western-blot analysis testing at a final dilution of 1/100 each serum sample. The predominant bands detected by Western-blot analysis will be identified by SDS-PAGE separation. Selected bands, corresponding to the immunogenic bands, will be excised, digested and identified with Mass Spectrometry analysis.
Study NCT03816007 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga and Mantram Repetition
Description: An existing yoga intervention designed for persons with chronic pain will be augmented with training in mantram repetition. The intervention meets 1x weekly for 75 minutes for 12 weeks, and includes a home practice component.
Study NCT03816007 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Veteran Calm
Description: A relaxation intervention used previously as a comparator intervention will be delivered by a health educator 1x weekly for 75 minutes for 12 weeks, and includes a home practice component.
Study NCT05437016 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HUBER exercises
Description: All the exercises involve mobility, flexibility and muscle strengthening exercises. Specifically, these exercises included self-awareness of the lumbo-pelvic-femoral complex and multidirectional mobility of the lumbar spine. We gradually integrated aerobic exercises and muscle strengthening of the lower limbs, trunk and spine extensors with bodyweight exercises. HUBER exercises require the synergistic activation of various muscle groups of the lower limbs, trunk and upper limbs to develop low-high force levels against the handles.
Study NCT05437016 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercises
Description: All the exercises involve mobility, flexibility and muscle strengthening exercises. Specifically, these exercises included self-awareness of the lumbo-pelvic-femoral complex and multidirectional mobility of the lumbar spine. We gradually integrated aerobic exercises and muscle strengthening of the lower limbs, trunk and spine extensors with bodyweight exercises.
Study NCT05264701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapist supervised exercise training
Description: Exercise training for 12 weeks will be given by video talk accompanied by a physiotherapist.
Study NCT05264701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training via phone app
Description: Exercise training for 12 weeks will be given over the developed phone application.
Study NCT05264701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity recommendations
Description: The program will be consist of 12 weeks of physical activity recommendations.
Study NCT05223972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Schroth Treatment
Description: Schroth exercises consist of passive and active postural auto-correction exercises done repeatedly and based on kinesthetic and sensorimotor principles. The ultimate goal of the Schroth method is to enable the patient to consciously maintain correct posture in their daily living activities. To achieve this requires repeating corrective movements performed to improve postural motor control. Schroth exercises also include strength and endurance training of postural muscles in order to improve the curve, raise the patient's self-image, and reduce pain. In this study, the Schroth exercises progressed from more to less passive support, from more to less feedback, and from lying to sitting or standing positions, according to the patient's ability to perform the specific exercise
Study NCT06019065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AJA001
Description: AJA001
Study NCT06019065 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06300983 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducative
Description: The intervention consiste of 5 sessions (Table 1), with each lasting 100 minutes and delivered on a weekly basis. Individual meetings will be conducted with each participant prior to starting the group work. These were considered pre-intervention sessions, during which patients provided informed consent to participate in the study and the first assessment tests were administered.
Study NCT06300983 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The control group, which do not receive any psychoeducative intervention
Study NCT05715424 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Six interventions for children and adolescents
Description: * Vision Health Record Establishment and Myopia Risk Assessment.~* Evaluation of vision care behavior and development of reasonable eye use behavior.~* Health education for teachers and parents.~* Action to improve the reading and writing environment at home and school.~* One hour of outdoor activities in and out of school during the day.~* Myopia grading management and medical correction action.
Study NCT06333977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LC542019
Description: oral dose, once daily
Study NCT06333977 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo
Study NCT03177681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tongue Assessment
Description: The coating on the top of the tongue assessed and categorized into three categories: no coating, thin coating and thick coating. The coating of the tongue may be related to the microorganisms in the intestine.
Study NCT03177681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stool Sample
Description: Stool sample collected at baseline and once during Days 3-7 and once during Days 8-12.
Study NCT03177681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Participants complete 4 questionnaires about symptoms in the past 24 hours, irritable bowel syndrome (IBS), most recent stool, and quality-of-life. Questionnaires completed at baseline and once during Days 3-7 and once during Days 8-12. Questionnaires should take about 30 minutes total to complete.
Study NCT03177681 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Holter Monitor
Description: Participants wear a Holter monitor for 20-24 hours to check nervous system and heart function at baseline and once during Days 3-7 and once during Days 8-12.
Study NCT03177681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yogurt
Description: Participants given 2 tablespoons (33 cc) of DannonÒ OikosÒ yogurt each day for 12 days.
Study NCT05505370 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy
Description: Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.
Study NCT05505370 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Description: Patients who meet all eligibility criteria were included and had a clinically indicated colonoscopy procedure performed using the study device. Immediately thereafter, patients had a colonoscopy procedure using standard colonoscope (Olympus CF 180) by a second endoscopist.
Study NCT05082181 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts)
Description: UPLIFT is an 8-week program that combines cognitive behavioral therapy (CBT) and mindfulness techniques and is delivered to small groups of participants by phone. Each weekly session is 1 hour long and is comprised of a check-in period, teaching on the week's topic, group discussion, a skill-building exercise, and a home practice assignment. CBT-related skills include thought monitoring, identifying cognitive distortions, problem identification, goal setting, and identifying supports. Relaxation exercises are also used for coping and to facilitate awareness of the body. Mindfulness activities include attention to breath, sights and sounds and other meditations. Audio guides are provided for home practice of mindfulness exercises.
Study NCT05082181 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BOOST (Bringing Out Our Strength Together)
Description: BOOST is a telephone-based support program delivered in 8 weekly group sessions. Each weekly session is 1 hour long and is comprised of a check-in period, introduction of the week's topic, and group discussion. Weekly BOOST session topics include: (1) personal experience of epilepsy; (2) personal experience of mood problems (depression, anxiety, stress); (3) seizure triggers; (4) concerns related to epilepsy treatment (e.g., medication adherence, side effects); (5) changes in seizures over time; (6) the impact of behavior (e.g., sleep, substance use) on seizures; (7) social relationships and epilepsy; and (8) review of the BOOST experience.
Study NCT06192030 — intervention group
Intervention type: OTHER
Intervention: Prediction model
Description: We develop and validate clinical models to predict patient survival and gene signatures in ovarian metastases of colorectal cancer.
Study NCT05318235 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05428111 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: flow cytometric immunophynotyping
Description: Expression of programmed death-1 (PD-1) \& programmed death ligand-1 (PDL-1) in flow cytometric immunophynotyping
Study NCT05780762 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IMPACT Program
Description: care at 3 levels:~(1) co-definition of the health situation, (2) co-planning of care and co-actions, and (3) co-assessment with the patient and with the team caring for him or her, and incorporating evidence-based measurement tools.
Study NCT05780762 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: usal care
Description: usual management with a Nurse in Advanced Practice.
Study NCT05450536 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Video Model and Role Play
Description: Video clips and role-play will be utilized to teach self-advocacy skills to autistic college students.
Study NCT05574868 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Rigicon Infla 10® Three-Piece Inflatable Penile Prosthesis
Description: Treatment: Erectile dysfunction
Study NCT01165606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy
Study NCT05480462 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Clodivac
Description: A dose of 0.5 ml should be administered intramuscularly into deltoid muscle.
Study NCT05480462 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Td-Impfstoff Merieux
Description: One dose (0.5 ml) intramuscular, preferably in the deltoid muscle of the upper arm.
Study NCT05414383 — intervention group
Intervention type: DEVICE
Intervention: CADx
Description: A novel CADx system for real-time histopathological prediction of colorectal neoplasia, by using non-magnified conventional white-light and image enhanced endoscopy.
Study NCT05359692 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: INCAGN01876
Description: INCAGN1876 will be adminstered via IV at at the protocol-defined dose and schedule according to cohort and treatment group enrollment.
Study NCT05359692 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: retifanlimab
Description: retifanlimab will be administered via IV Q4W